Both epidemiological and experimental studies have confirmed that IGF-1R expression in tumor tissue is significantly higher than in normal tissue, and its high expression is closely related to the aggressiveness and lethality of prostate cancer (15). This evidence concerns the gene IGF1R and prostate carcinoma.